{"id":"W2895870246","doi":"10.1186/s40425-018-0420-0","title":"Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study","year":2018,"lang":"en","type":"article","venue":"Journal for ImmunoTherapy of Cancer","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":180,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Alberta; University of Calgary; BC Cancer Agency","funders":"National Cancer Institute; Bristol-Myers Squibb","keywords":"Medicine; Pazopanib; Nivolumab; Sunitinib; Renal cell carcinoma; Tolerability; Discontinuation; Adverse effect; Internal medicine; Clinical endpoint; Oncology; Peripheral edema; Urology; Clinical trial; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006439441,0.0001827281,0.0005709768,0.000203161,0.00008385169,0.0000132206,0.0001160807,0.00003162967,0.0001386463],"category_scores_gemma":[0.00003553875,0.00009026068,0.00007043352,0.0003211861,0.0001578882,0.000105786,0.00001340064,0.0001949966,2.635915e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002493974,"about_ca_system_score_gemma":0.0003817083,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004481237,"about_ca_topic_score_gemma":0.001578339,"domain_scores_codex":[0.998467,0.0001335167,0.0006830574,0.0001668969,0.0003260175,0.0002235471],"domain_scores_gemma":[0.9986911,0.0002662129,0.0004902993,0.0002186604,0.0002876436,0.00004613096],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.5002815,0.007814197,0.1878711,0.0006764894,0.001264443,0.000280147,0.02953402,0.0002951683,0.1132658,0.00003771272,0.00009890672,0.1585805],"study_design_scores_gemma":[0.09194931,0.02702075,0.8177083,0.0005511792,0.0002654458,0.000149814,0.003605979,0.0001329122,0.05777229,0.00004098737,0.0006383928,0.0001646195],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9950663,0.002599109,0.00008110273,0.0002643559,0.00008855562,0.001798527,0.00001242053,0.000003738238,0.00008581805],"genre_scores_gemma":[0.997632,0.0007796071,0.0007122122,0.00005524634,0.000041316,0.00007361278,0.00000263143,0.0000341558,0.0006692333],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6298372,"threshold_uncertainty_score":0.3680724,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02981774737536692,"score_gpt":0.3328356411832563,"score_spread":0.3030178938078893,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}